Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Case Report Volume 4 Issue 11

COVID-19 as a Risk Factor for Ischemic Stroke, A Case Report, Khartoum, Sudan, 2020

Amira Sidig1, Mazin Salah-Eldien2, Khabab Abbasher Hussien Mohamed Ahmed2*, Hussien Abbasher3, Radi Tofaha Alhusseini2, Mohammed Abbasher4 and Abbasher Hussien5

1Associated Professor of Community Medicine, Al Neelain University, Faculty of Medicine, Khartoum, Sudan
2MBBS Student, University of Khartoum, Faculty of Medicine, Khartoum, Sudan
3MBBS Student, ALYarmouk College, Khartoum, Sudan
4MBBS Student at Al Neelain University, Faculty of Medicine, Khartoum, Sudan
5Professor of Neurology, University of Khartoum, Faculty of Medicine, Khartoum, Sudan

*Corresponding Author: Khabab Abbasher, MBBS Student, University of Khartoum, Faculty of Medicine, Khartoum, Sudan.

Received: April 03, 2021; Published: October 12, 2021



Introduction: Covid-19 is associated with common neurological diseases including stroke.

It is believed that COVID-19-19 can cause hypercoagulability status which can induce thrombotic events which may predispose for stroke.

Objective: To document COVID-19 as a risk factor for Ischemic Stroke.

Case Report: A 62 years Sudanese male known diabetic, hypertensive, hypercholesterolemia, presented to the casualty with left sided weakness. Full medical history and physical examination was done, routine and specific investigations were done.

Result: The patient, presented with left sided weakness, started suddenly. Both left upper and lower limbs were affected at the same time. He became completely paralyzed within less than six hours. Deviation of the mouth to the right side is noted. Physical examination revealed weakness in the left side of the body (left upper and lower limbs) where the power was grade zero in both limbs plus hypotonia and areflexia. Laboratory investigations were: Complete hemogram rather than lymphopenia no abnormalities were detected, ECG: left ventricular hypertrophy plus left access deviation, Chest X-ray showed evidence of cardiac enlargement and mid zonal pneumonia, chest showed evidence of bilateral ground glass appearance. Test for COVID-19 was positive, CT brain showed an evidence of right Cerebral infarction, D-dimer is elevated, C-reactive protein: 16.2mg/dl.

Conclusion: Strokes are being reported as a complication of COVID-19 due to the hypercoagulability state induced by Covid-19 infection.

Keywords: Covid-19; CT Brain; Chest X-ray



  1. Casadevall A and Pirofski LA. “The convalescent sera option for containing COVID-19”. Journal of Clinical Investigation 130 (2020): 1545-1548.
  2. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. JAMA 323 (2020): 1061-1069.
  3. McGonagle D., et al. “Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome”. Autoimmunity Review6 (2020): 102537.
  4. Kidwell CS and Warach S. "Acute ischemic cerebrovascular syndrome: diagnostic criteria". Stroke12 (2003): 2995-2998.
  5. Bamford J., et al. “Classification and natural history of clinically identifiable subtypes of cerebral infarction". The Lancet8756 (1991): 1521-1526.
  6. Harbison J., et al. “Rapid ambulance protocol for acute stroke". The Lancet9168 (1999): 1935.
  7. Hart RG., et al. “Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update". Stroke 4 (2017): 867-872.
  8. Steardo L., et al. “Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19”. Acta Physiology (Oxf) 229.3 (2020): e13473.
  9. Tsai LK., et al. “Neurological manifestations in severe acute respiratory syndrome”. Acta Neurology Taiwan 14 (2005): 113-119.
  10. Khosravani H., et al. “Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic”. Stroke6 (2020).
  11. Umapathi T., et al. “Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)”. Journal of Neurology 251 (2004): 1227-1231.
  12. Hoffmann M., et al. “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor”. Cell2 (2020): 271-280.e8.


Citation: Khabab Abbasher Hussien Mohamed Ahmed., et al. “COVID-19 as a Risk Factor for Ischemic Stroke, A Case Report, Khartoum, Sudan, 2020”. Acta Scientific Neurology 4.11 (2021): 18-21.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US